These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24320499)

  • 1. Four-dimensional Monte Carlo simulations demonstrating how the extent of intensity-modulation impacts motion effects in proton therapy lung treatments.
    Dowdell S; Grassberger C; Paganetti H
    Med Phys; 2013 Dec; 40(12):121713. PubMed ID: 24320499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractionated Lung IMPT Treatments: Sensitivity to Setup Uncertainties and Motion Effects Based on Single-Field Homogeneity.
    Dowdell S; Grassberger C; Sharp G; Paganetti H
    Technol Cancer Res Treat; 2016 Oct; 15(5):689-96. PubMed ID: 26208837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay effects in proton scanning for lung: a 4D Monte Carlo study assessing the impact of tumor and beam delivery parameters.
    Dowdell S; Grassberger C; Sharp GC; Paganetti H
    Phys Med Biol; 2013 Jun; 58(12):4137-56. PubMed ID: 23689035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of interplay effects on spot scanning proton therapy with motion mitigation techniques for lung cancer: SFUD versus robustly optimized IMPT plans utilizing a four-dimensional dynamic dose simulation tool.
    Yamano A; Inoue T; Yagihashi T; Yamanaka M; Matsumoto K; Shimo T; Shirata R; Nitta K; Nagata H; Shiraishi S; Minagawa Y; Omura M; Tokuuye K; Chang W
    Radiat Oncol; 2024 Sep; 19(1):117. PubMed ID: 39252032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
    Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
    Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
    Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of planned dose on different CT image sets to four-dimensional Monte Carlo dose recalculation using the patient's actual breathing trace for lung stereotactic body radiation therapy.
    Freislederer P; von Münchow A; Kamp F; Heinz C; Gerum S; Corradini S; Söhn M; Reiner M; Roeder F; Floca R; Alber M; Belka C; Parodi K
    Med Phys; 2019 Jul; 46(7):3268-3277. PubMed ID: 31074510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer.
    Grassberger C; Dowdell S; Lomax A; Sharp G; Shackleford J; Choi N; Willers H; Paganetti H
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):380-6. PubMed ID: 23462423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
    Liu C; Schild SE; Chang JY; Liao Z; Korte S; Shen J; Ding X; Hu Y; Kang Y; Keole SR; Sio TT; Wong WW; Sahoo N; Bues M; Liu W
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):479-489. PubMed ID: 29550033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
    Rana S; Greco K; Samuel EJJ; Bennouna J
    J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment planning and 4D robust evaluation strategy for proton therapy of lung tumors with large motion amplitude.
    Taasti VT; Hattu D; Vaassen F; Canters R; Velders M; Mannens J; van Loon J; Rinaldi I; Unipan M; van Elmpt W
    Med Phys; 2021 Aug; 48(8):4425-4437. PubMed ID: 34214201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical Note: 4D robust optimization in small spot intensity-modulated proton therapy (IMPT) for distal esophageal carcinoma.
    Feng H; Shan J; Ashman JB; Rule WG; Bhangoo RS; Yu NY; Chiang J; Fatyga M; Wong WW; Schild SE; Sio TT; Liu W
    Med Phys; 2021 Aug; 48(8):4636-4647. PubMed ID: 34058026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motion mitigation for lung cancer patients treated with active scanning proton therapy.
    Grassberger C; Dowdell S; Sharp G; Paganetti H
    Med Phys; 2015 May; 42(5):2462-9. PubMed ID: 25979039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors.
    Botas P; Grassberger C; Sharp G; Paganetti H
    Phys Med Biol; 2018 Jan; 63(3):035023. PubMed ID: 29219119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of four-dimensional (4D) Monte Carlo dose calculation in real-time tumor tracking stereotatic body radiotherapy for lung cancers.
    Chan MK; Kwong DL; Ng SC; Tam EK; Tong AS
    Med Phys; 2012 Sep; 39(9):5479-87. PubMed ID: 22957615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical 3D/4D cumulative proton dose assessment methods for thoracic tumours with large motion.
    Visser S; Korevaar EW; Muijs CT; Wijsman R; Langendijk JA; Pisciotta P; Gutteres Marmitt G; O Ribeiro C; Both S
    Radiother Oncol; 2023 May; 182():109575. PubMed ID: 36822356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical Note: Monte Carlo methods to comprehensively evaluate the robustness of 4D treatments in proton therapy.
    Souris K; Barragan Montero A; Janssens G; Di Perri D; Sterpin E; Lee JA
    Med Phys; 2019 Oct; 46(10):4676-4684. PubMed ID: 31376305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the interplay effects with proton scanning beams in stage III lung cancer.
    Li Y; Kardar L; Li X; Li H; Cao W; Chang JY; Liao L; Zhu RX; Sahoo N; Gillin M; Liao Z; Komaki R; Cox JD; Lim G; Zhang X
    Med Phys; 2014 Feb; 41(2):021721. PubMed ID: 24506612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative accuracy of 4D dose accumulation for lung radiotherapy using rigid dose projection versus dose recalculation on every breathing phase.
    Valdes G; Lee C; Tenn S; Lee P; Robinson C; Iwamoto K; Low D; Lamb JM
    Med Phys; 2017 Mar; 44(3):1120-1127. PubMed ID: 28019649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel four-dimensional radiotherapy planning strategy from a tumor-tracking beam's eye view.
    Li G; Cohen P; Xie H; Low D; Li D; Rimner A
    Phys Med Biol; 2012 Nov; 57(22):7579-98. PubMed ID: 23103415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.